EFFECTS OF POTENTIATED CHLORHEXIDINE ON BACTERIA AND TARSOCRURAL JOINTS IN PONIES

Citation
A. Klohnen et al., EFFECTS OF POTENTIATED CHLORHEXIDINE ON BACTERIA AND TARSOCRURAL JOINTS IN PONIES, American journal of veterinary research, 57(5), 1996, pp. 756-761
Citations number
31
Categorie Soggetti
Veterinary Sciences
ISSN journal
00029645
Volume
57
Issue
5
Year of publication
1996
Pages
756 - 761
Database
ISI
SICI code
0002-9645(1996)57:5<756:EOPCOB>2.0.ZU;2-S
Abstract
Objectives-To evaluate the bactericidal properties of chlorhexidine di acetate (CHD) after potentiation with EDTA and Tris buffer (EDTA-Tris) , and to find a potentiated CHD concentration that would achieve 90 to 100% killing for ail bacteria tested. Animals-6 adult ponies. Procedu re-Serial dilutions of CHD, CHD in EDTA-Tris, and EDTA-Tris alone were evaluated for bactericidal activity against Staphylococcus aureus, Es cherichia cell, and Streptococcus zooepidemicus. The tarsocrural joint s of 6 ponies were ravaged with either 1 L of phosphate-buffered salin e solution (control) or 1 L of 0.0005% CHD in EDTA-Tris. Synovial flui d was collected before lavage and on days 1, 4, and 8. Synovia, cartil age, and bone with cartilage were collected on day 8 when the ponies w ere euthanatized. Results-In vitro results indicated that 0.0005% CHD in EDTA-Tris was 90% lethal to all bacteria tested. Results of synovia l fluid analysis, glycosaminoglycan analysis, and histologic examinati on of the synovial membrane and articular cartilage indicated that joi nt lavage with 0.0005% CHD in EDTA-Tris was not detrimental to the syn ovium or the articular cartilage of pony tarsocrural joints. Changes o bserved were a result of the actual lavage process, the phosphate-buff ered saline solution, and hemarthrosis. Conclusions-A concentration of 0.0005% CHD in EDTA-Tris was 90% lethal to ail bacteria tested. Pony tarsocrural joint lavage with 0.0005% CHD in EDTA-Tris was not detrime ntal to the synovium or the articular cartilage. The efficacy of 0.000 5% CHD potentiated with EDTA-Tris as a potential joint lavage fluid fo r treatment of infectious arthritis needs to be evaluated in clinical patients.